Details of the Drug
General Information of Drug (ID: DMQZGNJ)
| Drug Name |
Sulfamic acid 4-sulfamoyloxy-butyl ester
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
1,4-Butanediyl sulfamate; Sulfamic acid, tetramethylene ester; 1,4-Butanediol, bissulfamate (ester); BRN 2275335; CHEMBL353258; 60548-62-1; Sulfamic acid 4-sulfamoyloxy-butyl ester; 4-sulfamoyloxybutyl sulfamate; AC1L3Y05; SCHEMBL11593067; DTXSID40209297; XHCZRWMTVBHWQT-UHFFFAOYSA-N; Bissulfamideoic acid 1,4-butanediyl; BDBM50159801; 1,4-Bis-O-sulfamyl-1,4-butanediol
|
||||||||||||||||||
| Indication |
|
||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 248.3 | |||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | -1.9 | ||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 7 | ||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 8 | ||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
| Drug-Molecule Activity Atlas (DMA)NEW | Click to Jump to the Detailed DMA Information of This Drug | ||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||||||||


